Hybrid approach holds promise for multi-vessel disease

04/29/2013 | Healio

Three years after undergoing hybrid coronary revascularization, patients with multi-vessel disease do better than those treated with either percutaneous coronary intervention or bypass surgery alone, according to a study in the Journal of the American College of Cardiology.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA